pharmaphorum.com Report : Visit Site

Technical data of the pharmaphorum.com

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host pharmaphorum.com. Currently, hosted in United Kingdom and its service provider is Rackspace Ltd. .

the related websites

wplgroup.com lse.co.uk genesisconference.com eyeforpharma.com ibo.org worldtravelguide.net climatehotmap.org noonsite.com advfn.com worldweatheronline.com pokerstars.net hamleys.com camvista.com 

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called Apache/2.2.15 (CentOS) containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

menu close search advanced search free search exact search search: category: select category events news partner content video views and analysis webinars white papers range: select range last week last month last quarter last year register sign in why register? home views & analysis digital debates white papers podcasts & videos partner content news events find an event live event coverage deep dive sales and marketing news views & analysis debates & insight partner content digital news views & analysis debates & insight partner content market access news views & analysis debates & insight partner content oncology news views & analysis debates & insight partner content patients news views & analysis debates & insight partner content r&d news views & analysis debates & insight partner content spotlight on disease spotlight: duchenne muscular dystrophy (dmd) disease spotlight: lhon the future of medical affairs the future of oncology clinical trials brexit advertise search search close trending roche’s alecensa fast-tracked in china merck launches map4health diabetes mobile app novo’s oral semaglutide on target in phase 3 trial vertex’s orkambi cf drug okayed for funding in australia astrazeneca to present the latest cardiovascular research in news news roche’s alecensa fast-tracked in china august 20, 2018 share x roche’s alecensa fast-tracked in china https://pharmaphorum.com/news/roches-alecensa-fast-tracked-china/ in news news merck launches map4health diabetes mobile app august 20, 2018 share x merck launches map4health diabetes mobile app https://pharmaphorum.com/news/merck-launches-map4health-diabetes-mobile-app/ in views and analysis collaborative working is key for the nhs and pharma august 20, 2018 share x collaborative working is key for the nhs and pharma https://pharmaphorum.com/views-and-analysis/collaborative-working-key-nhs-pharma/ in news views and analysis digital health round-up: hacking medical devices, robot pharmacies and more august 17, 2018 share x digital health round-up: hacking medical devices, robot pharmacies and more https://pharmaphorum.com/views-and-analysis/digital-health-round-up-hacking-medical-devices-robot-pharmacies/ latest news novo’s oral semaglutide on target in phase 3 trial novo nordisk continues to build a case for its oral semaglutide glp-1 class diabetes drug, with latest results share x novo’s oral semaglutide on target in phase 3 trial https://pharmaphorum.com/news/novos-oral-semaglutide-target-phase-3-trial/ vertex’s orkambi cf drug okayed for funding in australia committee recommends outcomes-based deal share x vertex’s orkambi cf drug okayed for funding in australia https://pharmaphorum.com/news/vertexs-orkambi-cf-drug-okayed-for-funding-in-australia/ astrazeneca to present the latest cardiovascular research astrazeneca and medimmune will present new data from its cardiovascular, renal and metabolism (cvrm) portfolio for the treatment share x astrazeneca to present the latest cardiovascular research https://pharmaphorum.com/news/astrazeneca-presents-latest-cardio-research/ see all views & analysis value-based healthcare: what’s it worth to you? it takes healthy people to make a healthy society – and that must be taken into account when share x value-based healthcare: what’s it worth to you? https://pharmaphorum.com/views-and-analysis/value-based-healthcare-whats-worth/ innovation and collaboration: key catalysts for scientific break-throughs during my time at illumina i had a realisation: restricted access to data, and an industry-wide aversion to share x innovation and collaboration: key catalysts for scientific break-throughs https://pharmaphorum.com/views-and-analysis/innovation-collaboration-key-catalysts-scientific-break-throughs/ the power of blockchain in cancer care transformation over the course of the last decade blockchain technology has slowly filtered through from the underground to the share x the power of blockchain in cancer care transformation https://pharmaphorum.com/views-and-analysis/blockchain-power-cancer-care/ see all deep dive magazine car-ts – a new weapon in the fight against cancer car-t – or chimeric antigen receptor t-cell therapies herald a new wave of therapies in cancer. car-t therapies share x car-ts – a new weapon in the fight against cancer https://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/ how to achieve digital success in pharma’s communications demystifying what digital means, empowering people to ‘think digitally’ and acting with confidence are game changing factors for share x how to achieve digital success in pharma’s communications https://pharmaphorum.com/views-analysis-digital/achieve-digital-success-pharma/ future-proofing pharma with a multichannel approach to sales and marketing deploying a multichannel approach to marketing, backed by the use of advanced analytics, could help pharma evolve and share x future-proofing pharma with a multichannel approach to sales and marketing https://pharmaphorum.com/views-analysis-sales-marketing/multichannel-marketing-sales-pharma/ see all webinars how to make digital work in medtech share x how to make digital work in medtech https://pharmaphorum.com/webinars/webinars-on-demand/make-digital-work-medtech/ engaging with hcps: what do hcps want from medical meetings? share x engaging with hcps: what do hcps want from medical meetings? https://pharmaphorum.com/webinars/webinars-on-demand/engaging-with-hcps-what-do-hcps-want-from-medical-meetings/ 04/12/2018 uk pharma and integrated health share x uk pharma and integrated health https://pharmaphorum.com/debates-insight-sales-marketing/uk-pharma-integrated-health/ see all white papers the changing face of pharmaceutical launches the industry has experienced a sustained period of change since its blockbuster heyday in the 1990s and continues share x the changing face of pharmaceutical launches https://pharmaphorum.com/market-access-2/digital-transforming-pharmaceutical-launches/ remote hcp engagement – still a struggle for life science companies life science companies are failing to achieve their full digital potential, particularly when it comes to the use share x remote hcp engagement – still a struggle for life science companies https://pharmaphorum.com/white-papers/remote-hcps-engagement-life-science/ medical meetings and what hcps want the healthcare professional (hcp) meeting landscape is evolving, but even as it adjusts to the demands of the share x medical meetings and what hcps want https://pharmaphorum.com/whitepapers/medical-meetings-and-what-hcps-want/ see all video raising the bar in liver cancer therapy share x raising the bar in liver cancer therapy https://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/ eisai’s emea ceo gary hendler on why quality of life is key to lenvima’s success share x eisai’s emea ceo gary hendler on why quality of life is key to lenvima’s success https://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/ part three: oncology shaping the future of personalised healthcare share x part three: oncology shaping the future of personalised healthcare https://pharmaphorum.com/video/part-three-oncology-shaping-future-personalised-healthcare/ see all partner content press releases event highlights for 13th annual industry leading cold chain distribution 2018 share x event highlights for 13th annual industry leading cold chain distribution 2018 https://pharmaphorum.com/partner-content/event-highlights-for-13th-annual-industry-leading-cold-chain-distribution-2018/ insightful developments and an exclusive interview from roche share x insightful developments and an exclusive interview from roche https://pharmaphorum.com/partner-content/insightful-developments-and-an-exclusive-interview-from-roche/ invitation from chair of this year’s immuno-oncology conference in london share

URL analysis for pharmaphorum.com

https://pharmaphorum.com/oncology/insights-oncology/eisais-emea-ceo-gary-hendler-lenvimas-success/
https://pharmaphorum.com/debates-insight-sales-marketing/uk-pharma-integrated-health/
https://pharmaphorum.com/market-access/views-analysis/
https://pharmaphorum.com/views-and-analysis/future-oncology-focus/
https://pharmaphorum.com/feed/
https://pharmaphorum.com/category/webinars
https://pharmaphorum.com/patients/news/
https://pharmaphorum.com/category/news
https://pharmaphorum.com/patients/
https://pharmaphorum.com/registration?iframe=true&width=400&height=378
https://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/
/pp-login.php?redirect_to=http://pharmaphorum.com/&iframe=true&width=450&height=370
https://pharmaphorum.com/category/press-releases
https://pharmaphorum.com/views-analysis-sales-marketing/multichannel-marketing-sales-pharma/
https://pharmaphorum.com/contribute/

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: PHARMAPHORUM.COM
Registry Domain ID: 1538102675_DOMAIN_COM-VRSN
Registrar WHOIS Server: whois.tucows.com
Registrar URL: http://www.tucowsdomains.com
Updated Date: 2016-12-16T18:15:55Z
Creation Date: 2009-01-19T09:02:07Z
Registry Expiry Date: 2021-01-19T09:02:07Z
Registrar: Tucows Domains Inc.
Registrar IANA ID: 69
Registrar Abuse Contact Email:
Registrar Abuse Contact Phone:
Domain Status: ok https://icann.org/epp#ok
Name Server: DNS1.UK2.NET
Name Server: DNS2.UK2.NET
Name Server: DNS3.UK2.NET
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last update of whois database: 2018-02-04T00:53:56Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

NOTICE: The expiration date displayed in this record is the date the
registrar's sponsorship of the domain name registration in the registry is
currently set to expire. This date does not necessarily reflect the expiration
date of the domain name registrant's agreement with the sponsoring
registrar. Users may consult the sponsoring registrar's Whois database to
view the registrar's reported date of expiration for this registration.

TERMS OF USE: You are not authorized to access or query our Whois
database through the use of electronic processes that are high-volume and
automated except as reasonably necessary to register domain names or
modify existing registrations; the Data in VeriSign Global Registry
Services' ("VeriSign") Whois database is provided by VeriSign for
information purposes only, and to assist persons in obtaining information
about or related to a domain name registration record. VeriSign does not
guarantee its accuracy. By submitting a Whois query, you agree to abide
by the following terms of use: You agree that you may use this Data only
for lawful purposes and that under no circumstances will you use this Data
to: (1) allow, enable, or otherwise support the transmission of mass
unsolicited, commercial advertising or solicitations via e-mail, telephone,
or facsimile; or (2) enable high volume, automated, electronic processes
that apply to VeriSign (or its computer systems). The compilation,
repackaging, dissemination or other use of this Data is expressly
prohibited without the prior written consent of VeriSign. You agree not to
use electronic processes that are automated and high-volume to access or
query the Whois database except as reasonably necessary to register
domain names or modify existing registrations. VeriSign reserves the right
to restrict your access to the Whois database in its sole discretion to ensure
operational stability. VeriSign may restrict or terminate your access to the
Whois database for failure to abide by these terms of use. VeriSign
reserves the right to modify these terms at any time.

The Registry database contains ONLY .COM, .NET, .EDU domains and
Registrars.

  REGISTRAR Tucows Domains Inc.

SERVERS

  SERVER com.whois-servers.net

  ARGS domain =pharmaphorum.com

  PORT 43

  TYPE domain

DOMAIN

  NAME pharmaphorum.com

  CHANGED 2016-12-16

  CREATED 2009-01-19

STATUS
ok https://icann.org/epp#ok

NSERVER

  DNS1.UK2.NET 77.92.66.24

  DNS2.UK2.NET 77.92.66.25

  DNS3.UK2.NET 77.92.66.26

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .